Sage Journals: Discover world-class research

Abstract

Objective: To describe trends in prevalent and incident stimulant prescribing between 2008 and 2017 in California. Method: Statewide trends were estimated by age and sex category for prevalent (any) and incident (no prescriptions in the preceding 2 years) stimulant prescribing while adjusting for area-level covariates. Results: Prevalent prescribing rates increased by 126%, while incident prescribing increased 23%. Patients aged 25 to 44 years experienced over 200% increases in prevalent prescribing and 34% to 55% increases in incident prescribing. Among patients older than 25, women had consistently higher prescribing rates than men. ZIP code tabulation areas with the largest minority populations had the lowest baseline prescribing rates but experienced the greatest annual prescription rate increases. Conclusion: Adult stimulant prescribing increased substantially for early working aged adults. Prescription rates were greater for women than men.

Keywords

prescription stimulants medication trends adult ADHD treatment

Get full access to this article

View all access options for this article.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

Bernardi

Faraone

S. V.

Cortese

Kerridge

B. T.

Pallanti

Wang

Blanco

(2012). The lifetime impact of attention deficit hyperactivity disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychological Medicine, 42, 875-887. doi:10.1017/S003329171100153X

Biederman

Petty

C. R.

Evans

Small

Faraone

S. V.

(2010). How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Research, 177, 299-304. doi:10.1016/j.psychres.2009.12.010

Burcu

Zito

J. M.

Metcalfe

Underwood

Safer

D. J.

(2016). Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014. JAMA Psychiatry, 73, 992-993. doi:10.1001/jamapsychiatry.2016.1182

Cassidy

T. A.

Varughese

Russo

Budman

S. H.

Eaton

T. A.

Butler

S. F.

(2015). Nonmedical use and diversion of ADHD stimulants among U.S. adults ages 18-49: A National Internet Survey. Journal of Attention Disorders, 19, 630-640. doi:10.1177/1087054712468486

Castle

Aubert

R. E.

Verbrugge

R. R.

Khalid

Epstein

R. S.

(2007). Trends in medication treatment for ADHD. Journal of Attention Disorders, 10, 335-342. doi:10.1177/1087054707299597

Centers for Disease Control. (2019). Parent-reported diagnosis of ADHD by a health care provider and medication treatment among children 4-17 years: National survey of children’s health—2003 to 2011—Data profiles by state. Retrieved from https://www.cdc.gov/ncbddd/adhd/stateprofiles/index.html

Chen

L. Y.

Crum

R. M.

Strain

E. C.

Alexander

G. C.

Kaufmann

Mojtabai

(2016). Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants. Journal of Clinical Psychiatry, 77, e297-e304. doi:10.4088/JCP.14m09291

Coker

T. R.

Elliott

M. N.

Toomey

S. L.

Schwebel

D. C.

Cuccaro

Tortolero Emery

. . . Schuster

M. A.

(2016). Racial and Ethnic Disparities in ADHD Diagnosis and Treatment. Pediatrics, 138(3), e20160407. doi:10.1542/peds.2016-0407

10.

Friedman

Kim

Schneberk

Bourgois

Shin

Celious

Schriger

D. L.

(2019). Assessment of Racial/Ethnic and Income Disparities in the Prescription of Opioids and Other Controlled Medications in California. JAMA Internal Medicine, 179, 469-476. doi:10.1001/jamainternmed.2018.6721

11.

Ganguly

Tian

Kong

S. X.

Hersloev

Hobbs

Smolarz

B. G.

. . . Weng

(2018). Persistence of newer anti-obesity medications in a real-world setting. Diabetes Research and Clinical Practice, 143, 348-356. doi:10.1016/j.diabres.2018.07.017

12.

Kessler

R. C.

Adler

Barkley

Biederman

Conners

C. K.

Demler

. . . Zaslavsky

A. M.

(2006). The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723. doi:10.1176/ajp.2006.163.4.716

13.

Kessler

R. C.

Adler

L. A.

Barkley

Biederman

Conners

C. K.

Faraone

S. V.

. . . Zaslavsky

A. M.

(2005). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biological Psychiatry, 57, 1442-1451. doi:10.1016/j.biopsych.2005.04.001

14.

Lakhan

S. E.

Kirchgessner

(2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain and Behavior, 2, 661-677. doi:10.1002/brb3.78

15.

Matte

Anselmi

Salum

G. A.

Kieling

Goncalves

Menezes

. . . Rohde

L. A.

(2015). A field trial in a large, representative sample of 18- to 19-year-old adults. Psychological Medicine, 45, 361-373. doi:10.1017/S0033291714001470

16.

McDonald

D. C.

Jalbert

S. K.

(2013). Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008. Psychiatric Services, 64, 1079-1086. doi:10.1176/appi.ps.004442012

17.

National Institute of Mental Health. (2016). Could I have attention-deficit/hyperactivity disorder (ADHD)? Retrieved from https://www.nimh.nih.gov/health/publications/could-i-have-adhd/index.shtml#pub2

18.

Oehrlein

E. M.

Burcu

Safer

D. J.

Zito

J. M.

(2016). National trends in ADHD diagnosis and treatment: Comparison of youth and adult office-based visits. Psychiatric Services, 67, 964-969. doi:10.1176/appi.ps.201500269

19.

Olfson

Blanco

Wang

Greenhill

L. L.

(2013). Trends in office-based treatment of adults with stimulants in the United States. Journal of Clinical Psychiatry, 74, 43-50. doi:10.4088/JCP.12m07975

20.

Paulozzi

L. J.

Strickler

G. K.

Kreiner

P. W.

Koris

C. M.

(2015). Controlled substance prescribing patterns: Prescription behavior surveillance system, eight states, 2013. MMWR Surveillance Summaries, 64(9), 1-14. doi:10.15585/mmwr.ss6409a1

21.

Piper

B. J.

Ogden

C. L.

Simoyan

O. M.

Chung

D. Y.

Caggiano

J. F.

Nichols

S. D.

McCall

K. L.

(2018). Trends in use of prescription stimulants in the United States and territories, 2006 to 2016. PLoS ONE, 13(11), e0206100. doi:10.1371/journal.pone.0206100

22.

Safer

D. J.

(2016). Recent Trends in Stimulant Usage. Journal of Attention Disorders, 20, 471-477. doi:10.1177/1087054715605915

23.

Seth

Scholl

Rudd

R. A.

Bacon

(2018). Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015-2016. Morbidity and Mortality Weekly Report, 67, 349-358. doi:10.15585/mmwr.mm6712a1

24.

Shiels

M. S.

Freedman

N. D.

Thomas

Berrington de Gonzalez

(2018). Trends in U.S. drug overdose deaths in non-Hispanic Black, Hispanic, and non-Hispanic White persons, 2000-2015. Annals of Internal Medicine, 168, 453-455. doi:10.7326/M17-1812

25.

United States Census Bureau. (2014). Overview of the 2010 ZIP Code Tabulation Area (ZCTA) Relationship Files. Retrieved from https://www.census.gov/geo/maps-data/data/zcta_rel_overview.html

26.

United States Census Bureau. (2018). American Community Survey (ACS). Retrieved from https://www.census.gov/programs-surveys/acs

27.

United States Census Bureau Population Estimates Program. (2018). Population and Housing Unit Estimates. Retrieved from https://www.census.gov/programs-surveys/popest.html

28.

United States Department of Agriculture. (2016). 2010 Rural-Urban Commuting Area (RUCA) Codes. Retrieved from https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/documentation/

29.

Vasilenko

S. A.

Evans-Polce

R. J.

Lanza

S. T.

(2017). Age trends in rates of substance use disorders across ages 18–90: Differences by gender and race/ethnicity. Drug and Alcohol Dependence, 180, 260-264. doi:10.1016/j.drugalcdep.2017.08.027

30.

Visser

S. N.

Lesesne

C. A.

(2005). Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder–United States, 2003. Morbidity and Mortality Weekly Report, 54, 842-847.

31.

Williamson

Johnston

(2015). Gender differences in adults with attention-deficit/hyperactivity disorder: A narrative review. Clinical Psychology Review, 40, 15-27. doi:10.1016/j.cpr.2015.05.005

32.

Yost

Perkins

Cohen

Morris

Wright

(2001). Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes & Control, 12, 703-711.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.48 MB